|Número de publicación||US4308866 A|
|Tipo de publicación||Concesión|
|Número de solicitud||US 05/957,258|
|Fecha de publicación||5 Ene 1982|
|Fecha de presentación||2 Nov 1978|
|Fecha de prioridad||2 Nov 1978|
|También publicado como||CA1146224A, CA1146224A1|
|Número de publicación||05957258, 957258, US 4308866 A, US 4308866A, US-A-4308866, US4308866 A, US4308866A|
|Inventores||Roger W. Jelliffe, Jack D. Crone|
|Cesionario original||University Of Southern California|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (8), Otras citas (17), Citada por (170), Clasificaciones (13)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
The invention pertains to apparatus employed in medically treating a patient, more particularly such apparatus which is employed to regulate the flow rate of a fluid used in treating a patient.
The progress of medicine over the years may perhaps somewhat inaccurately but usefully be thought of in terms of its progress from an "art" toward a "science". The development annd systematizing of information used in treating patients with drugs intravenously and through inhalation is particularly interesting. Computer programs which provide regimens of drug treatment based on systematized information and characteristics of a particular patient have in fact provided doctors in a number of instances with the capability to approach more closely the goals of such treatment while avoiding the pitfalls and dangers (e.g. inadequate or toxic levels of the drug in the bloodstream). See, e.g. R. W. Jelliffe, J. Rodman, and E. Kolb, "Clinical Studies with Computer-Assisted Lidocaine (L) Infusion Regimens", Circulation, Vol. 54, No. 4, Suppl. II, p. 211, 1976; R. W. Jelliffe, F. Goicoechea, D. Tuey, M. Wyman, J. Rodman and B. Goldreyer, "An Improved Computer Program for Lidocaine Infusion Regimens", Clinical Research, Vol. 23, p. 125A, February 1975; and R. W. Jelliffe, "A Computer Program for Xylocaine Infusion Regimens", Federation Proceedings, Vol. 32, No. 3, p. 812 Aab, 1973.
Focusing, by way of example, on the drug lidocaine and its use in the treatment of heart attack victims, an historical problem has been achieving sufficient serum levels as early as possible during the first hours of treatment and then reaching and maintaining a target serum level. At the same time, one of course wishes to avoid serum levels which are toxic or which approach toxicity. These goals are of course contradictory in nature, particularly in light of the problem of obtaining a uniform distribution of the drug in the bloodstream and the related delayed reaction of a patient to a change in the infusion rate. As indicated by the above references, computer programs are of significant value in balancing such goals. Further, in response to the requirements which may be called for by such programs, and also as a general matter, a capability to regulate a rate of flow of a drug to a patient in a somewhat automatic, systematic and safe fashion is of great interest to medical practitioners. This is particularly true if a capability to incorporate a large number of frequent changes, or to "fine tune", is included.
The opportunity to free medical personnel for other tasks to the extent that such drug treatment regimens can be mechanized has been somewhat recognized. For example, apparatus has been developed which employs a chart coated with a conductive material and a probe which will follow a curve scratched along the surface of the chart when the chart is placed on a rotating drum to move the curve past the probe. This apparatus may then be used in conjunction with e.g. an anesthesia pump. See catalog and specification material related to Qan, Inc. Dose Regulated Anesthesia Pump (Mark II) and Research, Inc. Model 5500 Data Trak Programmer incorporated in such pump; and H. J. Lowe, Ch. 7--"Automated Programmed Anesthesia", in Dose-Regulated Penthane (Methoxyflurane) Anesthesia, Abbott Laboratories, 1972. The scratched curve creates two isolated planes along the chart which become electrically energized with oppositely phased AC voltages when the chart is placed on the drum. The probe then seeks the zero potential scratched curve, and as it moves along the curve is used to mechanically adjust a potentiometer and thus affect an electrical signal.
A related but quite different approach employs the incorporation of the control of in-house, e.g. in hospitals, devices to control fluid flow rates, such devices themselves under the control of in-house computers. Such in-house systems are particularly adapted to a so-called closed loop operation involving evaluation by the computer of the condition of the patient being treated during such treatment, and adjustment under the control of the computer in light of such condition. Exemplary of this approach is a computer controlled intensive care unit at the University of Alabama Medical Center.
The present invention is directed to an apparatus and method for controlling the flow rate of a fluid for medically treating a patient, incorporating types and degrees of flexibility and safety of great interest and value to medical practitioners.
Such apparatus has the flexibility to control the flow rate of a fluid according to fluid flow rate information available from an individual, and available from a source electronic data processor, the available information representing sequences of flow rates and their durations. Thus, in accordance with the invention, such apparatus includes: operator input means for receiving flow rate information provided by the individual and for providing electrical signals representative of the information; source processor input means for receiving flow rate information provided by the source processor and for providing electrical signals representative of the information; and electronic data processing means for receiving such electrical signals, for providing and storing storage signals representative of such signals and for providing flow rate output signals, representative of the storage signals, for regulating the flow rate of the fluid. Regulator means may then be incorporated into the apparatus for regulating the flow rate of the fluid in response to the output signals. Similarly, the source processor input means may include means for electrically coupling the apparatus to and decoupling the apparatus from the source electronic data processor; and the electronic data processing means may include a portable power supply having a power capacity sufficient to power the apparatus.
Along related lines, and in accordance with the invention, a method of regulating the flow rate of a fluid for medically treating a patient may then include the steps of: coupling portable electronic control apparatus to an electronic information source having information representative of a sequence of fluid flow rates and their durations; providing the control apparatus with the sequence information; decoupling the control apparatus and source; transporting the control apparatus to the vicinity of a patient requiring medical treatment with the fluid; coupling the apparatus to a supply of the fluid; and regulating the flow rate of the fluid according to the sequence information. The method may then include the additional step of modifying the regulating to differ from the sequence while regulating according to the sequence, for example under the control of an operator of the apparatus.
Returning to the apparatus, in accordance with other, including certain flexibility, features of the invention, medical apparatus for controlling the flow rate of a fluid for medically treating a patient includes: storage means for storing electrical signals representative of a sequence of at least 8 discrete flow rates for the fluid and their durations; and execution means for automatically providing output signals corresponding to the sequence in response to the stored signals, upon initiation of such providing by the execution means; and a portable power supply having a power capacity sufficient to power the apparatus. It is noted that the discreteness of the flow rates is indicative of digital apparatus and the advantages thereof, while the number of fluid flow rates is indicative of a capability to approach the advantages of continuous variation, simple or complex, in a digital environment. It is additionally noted that the human mind is not psychologically adapted to readily remember more than 6 or 7 times. This is evidenced, for example, by telephone numbers. Also, a number of flow rates greater than 6, 7 or 8, e.g. 12 or 20, may of course be required for complex cases. Related to such features, and in accordance with method aspects of the invention, a method of regulating the flow rate of a fluid for medically treating a patient includes the step of providing an electrical signal representative of a sequence of at least 8 discrete fluid flow rates and their durations. The signal may then, for example, be independent of the condition of the patient; and the duration of the sequence may, for example, be for at least 8 hours.
In accordance with yet other apparatus aspects, including safety features, of the invention, medical apparatus for controlling the flow rate of a fluid for medically treating a patient includes: storage means for storing electrical signals representative of a sequence of discrete flow rates for the fluid and their durations; and execution means for providing output signals corresponding to the sequence in response to the storage signals; wherein the execution means includes means for providing a clocking signal for the execution means, and a frequency detector for providing an output signal representative of the frequency of the clocking signal. The execution means may then further include means for selectively testing the output signals of the execution means and frequency detector against predetermined standards and for providing a warning signal in the event of a divergence from such standards. In accordance with yet other apparatus aspects, including other safety features, such medical apparatus includes: storage means, as above; and execution means for providing output signals in response to the storage signals, as above, and for further providing at least one control signal for indicating an undesired mode of operation for the execution means; wherein the execution means includes means for interrupting the provision of the output signals in response to an indication of an undesired mode of operation by the control signal.
In an embodiment, output signals for transmittal to an infusion pump, of a power supply, and of a frequency detector monitoring a clocking signal frequency, may be selectively tested against predetermined standards, and provision is made for warning signals to an operator, controlled by the outcome of such testing.
In the drawings, exemplary embodiments demonstrating the various objectives and features hereof are set forth as follows:
FIGS. 1A and 1B are a block diagram showing medical apparatus in accordance with the invention in the context of a system incorporating the regulated provision of a fluid for medically treating a patient.
FIG. 2 is an illustrative timing diagram for the apparatus of FIGS. 1A and 1B.
As indicated above, detailed illustrative apparatus and method embodiments of the invention are disclosed herein. However, embodiments may be constructed and performed in accordance with various forms and acts, some of which may be rather different from the disclosed illustrative embodiments. Consequently, the specific structural, functional and performance details disclosed herein are merely representative, yet in that regard are deemed to provide the best embodiments for purposes of disclosure and to provide a basis for the claims herein which define the scope of the present invention.
In FIG. 1, apparatus 10, in the context of a system, is shown which is particularly adapted to receive information representative of sequences of fluid flow rates, such information being provided by an individual through a keyboard K, incorporated into the apparatus, and/or by an electronic data processor P through a terminal T for the processor; to store digital signals representative of such sequence information in a memory M; and to provide generally analog output signals, representative of such sequence information which may be stored, for driving an infusion pump IP through output lines 12. The infusion pump IP in turn mechanically controls the flow rate of a fluid from a syringe-type, storage-drive 13 for a supply of fluid 14 which is intravenously infused into the bloodstream of a patient PT through a tube 16 and a needle 20 penetrating the bloodstream of the patient. A Harvard Model 2620 infusion pump, for example, is particularly well adapted to implementing the function of the infusion pump IP of FIG. 1.
An input interface 22 receives the flow rate information provided by the individual through the keyboard K and provides digital electrical signals representative of the information to the memory M. The flow rate information so provided is received and stored in a random-access portion 23 of the memory M (RAM). Along somewhat similar lines, flow rate information provided by the electronic data processor, which in turn is provided by the processor terminal T, is received for input into the apparatus 10 by a terminal-CPU interface 24 which provides digital electrical signals representative of such information to a central processing unit CPU, which places the flow rate information (and other types where necessary) in a form compatible for the memory M and for operational use by the apparatus 10 before providing the flow rate information (in digital form) to the RAM 23 for storage.
While the apparatus 10 is operating to provide its output to the infusion pump IP, various safety functions are carried out by the apparatus. Such functions include the selective testing of the output of the apparatus, of a power signal V1 for the apparatus from a portable power supply 26, and of the output signal of a frequency detector 28, representative of the frequency of a clocking unit 30 for the apparatus. The selective testing is carried out by the selection of the signal to be tested by an analog device selector 31 according to signal-represented information from the memory M, and the conversion of the generally analog signal to a digital representation for comparison with digitally-represented standards for such signals stored in the memory. Warning signals, implemented alphanumerically in a display panel DP, through display panel warning lights 32 and 34 and through a display panel sound alarm 36 (for warnings related to these and other functions), are employed to warn an operator of divergences from such standards. (As is indicated in FIG. 1, the warning lights, sound alarm and a visual display, all addressed in detail subsequently, are in a common display panel.) In addition, the absence of a high pulse along either of the control signals FS1 and FS2, over an unexpectedly long interval, such absence being in certain circumstances indicative of an undesired mode of operation for the central processing unit CPU, will cause a relay associated with the signal in fail safe relay circuitry 40 to open and interrupt the provision of the output of the apparatus to the infusion pump IP.
Typically, either the electronic data processor P or the keyboard K is used to provide a sequence of up to 20 flow rates and their durations. In this regard, a conventional program is incorporated in a first read-only portion 42 of the memory M (ROM(A)) to interact with the electronic data processor P through the central processing unit CPU, terminal-CPU interface 24 and processor terminal T. A conventional, monitor program, e.g. implemented on a 512 word read-only memory portion, having 8-bit words, may be conveniently used in the apparatus, for implementing the interaction. Also, the communication between the electronic data processor P and the processor terminal T might be conveniently implemented over a telephone line, the terminal then having an acoustic to digital transducer to permit intercommunication between the electronic data processor P and the apparatus. The terminal-CPU interface 24 then may be readily implemented using the well known RS-232C communication protocol in the interface 24. With a view toward flexibility and toward compatibility with the above, in the system of FIG. 1 it may then be assumed that the information received by the interface 24 and provided to the central processing unit CPU of the interface is in the American Standard Code for Information Interchange (ASCII), and that such information is converted by the central processing unit to a form for storage in the RAM 23. In the system of FIG. 1, this form is, along conventional lines, assumed to be standard binary coded decimal (in some cases, e.g. a signal-represented flow rate about to be used, converted to standard binary by the central processing unit and also stored in that form for immediate use), and a RAM 23 having a capacity of 256 8-bit words is deemed adequate for the 20 flow rates and durations and for other signals which the RAM 23 is employed to store.
A second read-only portion 44 of the memory M (ROM(B)) is employed to store another conventionally-implemented program for controlling the interaction of the apparatus with, ultimately, the individual who might provide sequence information, and for controlling the operation of the apparatus in accordance with sequence information and, generally, in accordance with the various safety and related functions of the apparatus. A capacity of 4096 8-bit words is certainly adequate for the ROM(B) 44, and a capacity of half that size is considered at least marginally sufficient.
During the provision of initial sequence information through the keyboard K, a digitally-represented data signal (e.g., a number in a flow rate sequence) or a digitally-represented input control signal may be stored in an input register in the input interface 22. The transmission of such a stored, digitally-represented signal, however, is controlled by the occurrence of a pulse along an apparatus control signal IOTI, as indicated in FIG. 1, which will not occur unless a status signal ST from the interface (caused to go high by receipt of an input by the interface) to the central processing unit CPU indicates that a new input has occurred. The presence of a subsequent digitally-represented input control signal (e.g., ENTER) in the input register in the interface 22, indicating that the individual has decided to enter the just-provided input for incorporation into the operation of the apparatus, will permit such incorporation. Alternatively, such incorporation might be blocked by, e.g., a CLEAR signal entered subsequently to the prior input signal, but before an ENTER signal has been provided to the input register.
The apparatus is programmed (ROM(B) 44) to provide the control signal IOTI (if the status signal ST is high) at intervals both during an initial input procedure from the keyboard K and during operation of the apparatus to regulate the flow rate of the fluid 14. This will be treated in somewhat more detail below. However, for present purposes it is emphasized that the occurrence of this signal during such operation enables the incorporation into such operation of modifications in an initially input flow rate sequence during the performance of the sequence by the apparatus. For safety, among other reasons, it is considered beneficial, however, to provide only a limited capability for such modifications. More specifically, through the program in the ROM(B) 44, the incorporation of a GO TO modification of a previously input sequence during the performance of the sequence or an ADJUST modification during such sequence are considered beneficial and consistent with safety requirements. The GO TO with the related data is to provide a jump to the beginning of a subsequent or earlier infusion number in the sequence and to continue the sequence from that point (or to the beginning of the current infusion number to continue, starting at the beginning of the running of the time for that number). The ADJUST is to adjust the current and all subsequent flow rates by a multiplication factor ranging, e.g., from 0.1 to 9.9.
The apparatus is adapted to implement such modifications, through keyboard input of data and input control signals (e.g., GO TO and ADJUST), which interact with, e.g. the ENTER and CLEAR input control signals, along the lines noted above, independently of whether the initial sequence information was provided through the keyboard K or by the processor P. The changes are of course implemented through the eventual storage of digitally-represented modification signals in the RAM portion of the memory M, e.g., during the regulation of the flow rate of the fluid 14.
Before proceeding to the operation of the apparatus of FIG. 1 as it regulates the flow rate of the fluid 14, it might be noted that in FIG. 1, the communication between the processor terminal T and the terminal-CPU interface 24 is serial, i.e. one bit at a time (e.g., in the ASCII code). Similarly, the communication between the terminal-CPU interface 24 and the central processing unit CPU is also serial (e.g., also in ASCII). Thus, although many of the apparatus control signals (to be described, being somewhat analogous to the apparatus control signal IOTI) which occur during such regulating operation of the apparatus will also occur while the processor P and the apparatus are interacting during the receipt of initial sequence data by the apparatus, the actual operation inside the central processing unit CPU during such receipt will not be typical of the regulating operation mode. Thus, during such receipt of initial sequence information provided by the processor P, the central processing unit CPU will be interacting with the processor P, receiving digitally-represented information provided serially, and interpreting that information and translating at least some of the information into, e.g., standard binary coded decimal.
Also, before proceeding to the regulating operation of the apparatus, it will be appropriate to describe the mode of start-up of the apparatus and several other aspects of the apparatus.
In the apparatus of FIG. 1, start-up is accomplished through conventionally-implemented apparatus and interactions, including start-up control circuitry 46. Start-up is initiated by a pushing of, e.g. a POWER keyboard button, resulting in a high pulse along a start-up signal SU, which in turn causes a high pulse along a clearing signal CL from the start-up control circuitry 46 to the central processing unit CPU and a number of other elements of FIG. 1. This clearing signal CL is employed to clear stale signal-represented information in the central processing unit and various of the other elements which should be cleared prior to start-up. The clearing may for example be accomplished along the rising edge of the high pulse along the control signal CL. Other modes for these signals and for such start-up will be readily apparent. In FIG. 1, the start-up control circuitry 46 includes a capacitor-resistor interaction to delay, e.g. for 2 milliseconds, the rising of another start-up signal P to a level sufficient to transfer control to the central processing unit CPU. Following such transfer of control, as a safety precaution of particular concern in medical apparatus, the integrity of each RAM storage location may be checked under the control of start-up aspects incorporated into the ROM(A) program, prior to the receipt of processor or keyboard provided sequence information. By integrity, is meant the capability of such storage location to have signal-represented information written into it and read out of it. In the event of a problem in this regard, a warning signal may be provided generally along lines described in another context below, and, for example, the program may deactivate the apparatus (or provide a zero output). The central processing unit CPU will in the absence of an indication to the contrary (next paragraph) assume that it is to receive initial input flow rate information from an individual through the keyboard K. In this "keyboard" case, a "keyboard-case" word in the memory M will be addressed to start the receipt of such information.
In the processor input, or "processor", case, the central processing unit CPU will sense through a signal along a serial input line 48 from the terminal-CPU interface 24, controlled by the electronic data processor P, that the apparatus has been electrically coupled to the processor P to receive flow rate sequence information from the processor. In this case, the central processing unit CPU will start the receipt of information by addressing another "processor-case" word in the memory M. The electronic data processor P, central processing unit CPU and ROM(A) program can then interact to provide the RAM with the sequence information from the electronic data processor P. The sequence information in the aforementioned processor case may be checked following input, by interaction between the ROM(A) program and the electronic data processor P, to provide a warning signal and/or deactivation (or a zero output) in the event of a problem.
The foregoing safety precaution and checking interactions and capabilities (RAM storage location integrity and checking of sequence information) are conventionally implemented and well-known and understood by those skilled in the art.
Upon completion of the desired interaction, in the so-called "processor" case, between the processor P and the apparatus, the receipt of a termination signal along the serial input line 48 will indicate to the central processing unit CPU that its interaction with the processor P should be ceased. The apparatus may then be electrically decoupled from the processor terminal T. Then, if the patient PT, or the patient together with infusion pump IP, is at a different location, the apparatus may be transported from the location where it was coupled to the processor P to the vicinity of the patient PT, or patient and infusion pump IP, to be coupled to the fluid 14 and to then perform the desired regulating of the flow rate of the fluid 14.
The capability of the apparatus to receive input information from the processor P without a human interface is considered a significant advantage. Thus, where the critical safety concerns of medical apparatus are present, and complicated regimens for using drugs are desired, e.g. including up to 20 flow rates and their durations, it is deemed of great concern from a safety standpoint to not interface an individual in the provision of the sequence information that will control the flow rate of, e.g., a potentially hazardous drug. This is particularly true where the drug may be infused over long periods when an attendant is not present or may be occupied with other duties or when the attendant is not knowledgeable with regard to the treatment or the operation of equipment which is being used. This is particularly critical in the instant situation in which one may desire to provide the patient with the drug treatment without the monitoring that would be required in the absence of apparatus such as the present apparatus having a capability to automatically control a complicated infusion regimen. The capability of the apparatus to be coupled and decoupled to a source processor P, through e.g. a simple connector used in implementing an RS-232C communication protocol (e.g. incorporated in the terminal-CPU interface 24), and to be transported away from the location of such coupling to a location of a patient PT, e.g. in an ambulance, is also considered to be a significant advantage. In implementing this adaptability to transport, or portability, the power supply 26 for the apparatus is of importance.
As in part indicated by FIG. 1, the power supply 26 provides three DC output signals for powering the apparatus. The power signal V1 in FIG. 1, referred to previously, is a "lower" voltage signal, e.g. +5 volts. Two other signals have greater absolute values, e.g. +15 volts. As indicated in FIG. 1, the elements of the apparatus of FIG. 1 are essentially completely powered by only these three power signals. The low power requirement of the apparatus in fact enables the implementation of the power supply 26 with standard alkaline D-cells. Thus, in the apparatus of FIG. 1, the power supply 26 is implemented, with safety requirements in mind, through two separate packs of such D-cells (each pack having a number of cells in series and in parallel to provide adequate voltage and current). Based on the power requirements of the apparatus, eack pack is designed to have a capability to power the apparatus for in the range of 20 hours, providing a total storage capacity sufficient to power the apparatus for at least approximately 30 hours and in fact in the range of 40 hours. (A capacity to so power the apparatus for at least 8 hours would of course cover a typical working shift.) When the first pack becomes low, the power supply will be switched to the second pack along lines which will be explained in more detail below. For the purposes of the present discussion it need only additionally be noted that the ± higher absolute value signals may be readily derived from lower absolute value D-cell voltages through conventional methods, and that two key factors in limiting the power requirements of the apparatus are the liberal use of CMOS technology in implementing the central processing unit CPU and related elements, and the liberal use of liquid crystals in implementing the display panel DP for the apparatus. Such crystals may be used to implement, among other information, alphanumeric information provided by the panel. Certain of the alphanumeric information provided by the display panel DP of FIG. 1 is of some interest and will thus be briefly described. It will be evident that this information is in many respects related to the keyboard initial input and modification processes which have been previously described.
First of all, with respect to the entry of initial sequence information through the keyboard, the display is adapted to provide the following important instructional information: ENTER RATE to indicate to an operator to enter a rate for a sequence position; and ENTER TIME to similarly call for the entry of the duration for a sequence position. Then, generally during regulating operation, which may include the aforementioned modification processes, the display is adapted to provide the following information, some of which relates to keyboard inputs: RUN to indicate the apparatus is operating to regulate the flow rate of a fluid; ENTER GO TO to tell the operator that he has pushed a GO TO keyboard button and should provide the number for the sequence position he wishes to go to in modifying the sequence; ENTER ADJUST to similarly tell the operator he has pushed an ADJUST keyboard button and should now enter the adjustment factor to modify a sequence; ALTERED PROGRAM to indicate that a sequence has been altered by a GO TO or ADJUST; CONTINUE LAST INFUSION to indicate that the sequence calls for continuing the last flow rate in the sequence indefinitely; LAST INFUSION STOP to, by way of contrast, indicate that the sequence information calls for terminating the infusion after a definite infusion interval for the last position in the sequence; END to indicate the end of a sequence has been reached and the infusion has terminated; SERVICE to indicate a divergence in the output from predetermined standards in the RAM 23, tested in a way which will be explained in more detail below; the infusion number in a sequence; the infusion rate entered for that number; any adjustment factor entered in modifying a sequence and the rate entered times the adjustment factor; the total time elapsed since the infusion was commenced; and, available to replace the elapsed time upon triggering of a TOTAL MILLILITERS INFUSED keyboard button, the total volume of fluid infused since the commencement of the sequence.
Of related interest, in addition to the keyboard push buttons and/or push button instructions previously explicitly or implicitly noted, e.g. CLEAR, ENTER, GO TO, ADJUST, TOTAL ML INFUSED, CONTINUE LAST INFUSION, numbers to enter rates and times, POWER to turn on the power to inititate start-up, other buttons (and functions) of note include a START button (and function) to start a regimen, and a STANDBY button (and function) to hold a sequence in suspension to e.g. change a syringe. In addition, an input button (function) capability conveniently called REVIEW is useful to provide a display panel review of the initially input flow rates and durations starting with the first triggering of the button at the first infusion number. Each subsequent triggering would then result in the provision of display information for the next infusion number. A capability may then be included to leave the review procedure without carrying out a full review and to revert to the nonreview display information after an interval (e.g. 20 seconds) following initiation of review. A great many variations in display information and input buttons and functions are of course possible, and may be readily implemented.
Now finally returning to the regulating operation of the apparatus to provide a sequence of flow rates, incorporating the modification features previously noted and initiated through keyboard inputs, such operation can be readily understood by reference to various of the control signals shown in FIG. 1.
Referring to that figure, the timing for the central processing unit CPU is controlled by a clocking signal C from a conventional crystal clocking unit 30. A clocking signal having a frequency of, for example 2 megahertz, is appropriate for the operation of the system of FIG. 1. A typical clocking signal C, assumed herein to be operative, is represented in FIG. 2(a). The clocking signal controls the output of control signals T1, T2, R and W from the central processing unit CPU.
As shown in FIG. 2(b) and 2(c), the central processing unit places a high pulse along the control signal T1 near the beginning of an 8 clock pulse central processing unit cycle and similarly places a high pulse along the control signal T2 near the end of the cycle. Similarly, as indicated in FIG. 2(d) and 2(e), the central processing unit places a high interval along the control signal R, indicating a "read" interval during a cycle, along an interval starting near the middle of the high pulse along the control signal T1 and ending after the falling edge of the high pulse along the control signal T2, or a high interval along the control signal W, indicating a "write" interval during a cycle, beginning somewhat after the middle of the cycle and ending near the time marking the middle of the high pulse along the control signal T2. Typically, the central processing unit continuously puts out these four control signals, the high pulses along the control signals T1 and T2 occurring for each eight clock pulse cycle, and either the high interval along the control signal R or the high interval along the control signal W occurring during a cycle, but not both.
The interaction between the central processing unit CPU and memory M by which signal-represented information may be transferred between the two elements or by which the memory may be enabled to transmit stored, signal-represented information to various of the other elements or receive signal-represented information from various of the other elements, is readily understood in light of the aforementioned control signals and other timing aspects illustrated in FIG. 2. In FIG. 1, it is assumed that such data communication between the central processing unit and memory, and in fact generally between the memory and other digital elements, is generally in parallel, no more than 8 bits at a time. Other choices are of course readily available and possible.
Proceeding along these lines, the addressing of the desired portion (ROM(A) 42, ROM(B) 44 or RAM 23) and storage location in a portion of the memory M is accomplished, first, by the output by the central processing unit of a number of bits including higher order bits of an address requiring more than 8 bits, which bits are received by an address register in a CPU-memory interface 50 and stored along the rising edge of a high pulse along the control signal T1. These first addressing bits are followed during the same cycle by bits which include the remaining required address information. The timing of the transmittal of both the former and these latter bits is represented in FIG. 2(f), where the interval for transmitting the first part of the addressing information is shown by a portion labeled ADD1 and the interval for the second, by the portion labeled ADD2.
After the CPU-memory interface 50 has stored the first group of bits and received the second group, it may then transmit the full address, requiring both groups, to the memory M. It is noted that the interface need not store the second group of bits. Thus, the full address will be stabilized during a "read" interval somewhat after the commencement of the high period along the control signal R, and during a "write" interval, well before the onset of the high period along the control signal W.
Assuming a "read" interval and the transmittal of information from the memory (e.g. the ROM(A) 42, from a storage location containing an instruction for the central processing unit) to the central processing unit, the central processing unit will be enabled to receive the signal-represented information during a period represented by the high pulse along the timing signal labeled CPU DATA IN in FIG. 2(j), and the memory will be transmitting the correct information after the addressing information has stabilized. An internal data-in register in the CPU may then store this information along the rising edge of a clock pulse occurring while the central processing unit is enabled to receive information (while CPU DATA-IN is high). On the other hand, assuming that information is to be transmitted by the central processing unit to the memory M, the timing signal in FIG. 2(h), labeled CPU DATA OUT, represents, while it is high, an interval during which the central processing unit will be transmitting information; and the desired storage location in the memory may then receive the transmitted information after the onset of the high interval along the control signal W, and store it along the falling edge of the control signal. This sort of interaction is of course well understood. In this regard, it is noted that the functions of a central processing unit such as that in the system of FIG. 1 may be readily implemented using the RCA CDP1802 CMOS Microprocessor. See COSMAC Microprocessor Product Guide (MPG-180A), RCA Corporation, 1977.
In addition to generating the control signals T1, T2, R and W, signal-represented addressing information for the memory, as well as other signals, the central processing unit CPU also transmits control signals IOT to an I/O and testing controller 52. In FIG. 1, these signals are transmitted along a control cable 54, and are assumed to be three signals transmitted in parallel along the control cable. Further, any or all of these signals may have a high interval during any central processing unit cycle, beginning near the rising edge of a high pulse along the control signal T1 and ending near the falling edge of a high pulse along the control signal T2. Also, during any such cycle, all of these signals may lack a high pulse, and thus be in a low state. The timing of a high interval along an IOT control signal is represented in FIG. 2(g). In response to the IOT control signals, the I/O and testing controller 52 may, during a central processing unit cycle, provide a high interval along any one of eight control signals emanating from it which control various of the input and output, as well as safety and testing, functions of the apparatus.
The eight control signals from the I/O and testing controller 52 are logically generated in conventional fashion from the three input IOT control signals from the central processing unit, and from the control signals R, W and T2, also received by the I/O and testing controller 52 from the central processing unit. The three IOT control signals, representing a possible seven alternative combinations in which at least one of the signals has a high interval during a cycle, are each sensed in conventional fashion by the I/O and testing controller 52. The IOT and testing controller in turn provides a high interval along one of six internal signals, each associated with one of six of the combinations which are employed, during essentially the same interval as the one or more IOT control signals are high. These internal signals, which will be generically called IOTG, are used to provide a high interval during a cycle with a "read" interval, along one of the following groups of control signals transmitted by the I/O and testing controller 52: IOTA, IOTD, ITOC, IOTS, IOTLI and IOTHI. In the system of FIG. 1, this is accomplished by the logical operations IOTG and R, performed for each of the internal IOTG signals. Thus, during a "read" cycle, one of the aforementioned group of control signals transmitted by the controller 52 may have the high interval along it represented by the timing diagram of FIG. 2(h). However, of course, one of this group need not necessarily have a high interval during such a "read" cycle. Similarly, three of these same six internal IOG signals are employed to generate high intervals which may occur during "write" cycles along the following control signals transmitted by the I/O and testing controller: IOTI, IOTLO and IOTHO. Such high intervals are accomplished by the logical operations (IOTG AND W) OR T2, performed for each of the group of three signals from the group of IOTG signals. Again, any one of the signals IOTI, IOTLO and IOTHO may have a high pulse during a "write" cycle, as illustrated in FIG. 2(i), but there need not be a high pulse along one of them during such a cycle. The described techniques for providing the control signals tramsitted by the IOT and testing controller 52 are commonly employed; and in light of the above and the later detailed explanation of how such controlled signals are employed, a great many variations which satisfy the requirements herein will be readily apparent.
With the above understanding, the way of accomplishing input, output and various testing and safety functions of present interest is readily understood. The functions referred to encompass the input of information from the input interface 22 to modify (during regulating operation) a flow rate sequence; the receipt and storage of a digitally-represented flow rate from the RAM 23 by a digital to analog conversion system 56 and the conversion of the digitally-represented flow rate signal to an analog signal for output; the selective testing of such signal (and, through this, testing of the signal at the output lines 12), of the generally analog power signal V1, and of the generally analog output signal of the conventionally implemented frequency detector 28, representative of the frequency of the clocking signal C; and the updating of display panel information.
As is evident from the figure and from the above discussion of the control signals provided by the I/O and testing controller 52, the testing may be accomplished by alternative selections by the conventionally implemented analog device selector 31, according to signal-represented device addressing information received from the RAM 23, and by the transmittal of the selected signal to an analog to digital conversion system 60 which, after converting the received analog signal to a digital representation, provides the digital representation to the RAM 23 for comparison by interaction betweeen the central processing unit CPU and memory M, with predetermined standards fo the signal. In the case of the output signal of the digital to analog conversion system 56, the predetermined standard would be the signal-represented information representing the flow rate which had been transmitted to the analog to digital conversion system. In the case of the power supply signal V1, it would be a digitally-represented range of acceptable voltage levels (e.g. 4.75 to 5.00 volts). And in the case of the output signal from the frequency detector 28, it would typically be a digitally-represented range of acceptable frequencies for the clocking signal.
With respect to updating the display, this function is, summarily, accomplished by, first, the receipt and storage of signal-represented addressing information, e.g. for a given digit, by a memory-display and fail safe interface 62, and the subsequent receipt and storage by the interface 62 of signal-represented data, e.g. for this digit, which is then received and stored by the display.
Before addressing these functions and other matters in somewhat more detail, it will be valuable to provide a glossary of various relevant signals, as follows:
______________________________________ Source Element(s) To SummarySignal Element Which Provided Functional Description______________________________________R CPU CPU-Memory Defines "Read" interval Interface; during CPU cycle; en- Memory; I/O and ables memory to be read Testing Con- trollerW CPU CPU-Memory Defines "Write" inter- Interface; val during CPU cycle; Memory; I/O and enables memory to store Testing Con- input signal along troller falling edge of control signalIOTI I/O and Input inter- Input register in inter- Testing face face transmits stored Control- input signal while con- ler trol signal is high.IOTA I/O and Memory-Display Address register in Testing and Fail Safe interface stores Control- Interface display address sig- ler nal along falling edge of control signalIOTD I/O and Memory-Display Display register in inter- Testing and Fail Safe face stores display data Control- Interface signal along falling edge ler of control signalIOTS I/O and Analog Device Address register in Testing Selector selector stores device Control- address signal along ler falling edge of control signal, selecting analog signal to be transmitted by selectorIOTC I/O and Analog to Digi- System starts conversionAND Testing tal conversion along falling edge ofSC Control- system IOTC AND SC ler and Memory (through logic gate)IOTLO I/O and Analog to Digi- System transmits part, Testing tal conversion including lower order Control- system bits, of digital out- ler put signal while control signal is highIOTHO I/O and Analog to Digi- System transmits part, Testing tal conversion including higher order Control- system bits, of digital output ler while control signal is highIOTLI I/O and Digital to Ana- System stores part, in- Testing log conversion cluding lower order bits, Control- system of digital input along ler falling edge of control signalIOTHI I/O and Digital to Ana- System stores part, in- Testing log conversion cluding higher order bits, Control- system of digital input along ler falling edge of control signalIOTC I/O and Digital to Ana- System starts conversionAND Testing log conversion along falling edge ofLCR Control- system IOTC AND LCR through ler and storage of digital signal Memory for conversion in conver- (through sion register in system logic gate)IOTC I/O and Power Supply Supply switches to secondAND Testing battery pack along fallingSBP Control- edge of IOTC AND SBP ler and Memory (through logic gate)FS1 Memory- Fail Safe Relay Maintains closure of a Display Circuitry first relay in circuitry and Fail to permit passage of out- Safe put signal to infusion Interface pump when frequency of (through high pulses along control logic) signal is sufficientFS2 Memory- Fail Safe Relay Maintains closure of a Display Circuitry second relay in circuitry and Fail to permit passage of out- Safe put signal to infusion Interface pump when frequency of (through high pulses along control logic) signal is sufficientCI Interrupt Interrupts CPU along CPU rising edge of control Clocking signal to instruct CPU Unit to include input from input interface (if ST signal is high) and dis- play updating in the operations being car- ried out______________________________________
As mentioned earlier, the interaction of the input interface 22 with the memory M, even with an individual rapidly working the keyboard K, would not generally require a capability to receive an input signal by the memory at intervals shorter than 100 milliseconds. Thus, referring to the control signal CI above, an interrupt clocking unit 64 acts along conventional lines in effect as a frequency divider to provide an interrupt clocking signal CI having a frequency, e.g. with a 2 megahertz clocking signal C, of 10 Hertz and a period of 100 milliseconds. Essentially the same situation obtains with the display DP and the memory-display and fail safe interface 62 in that it is not considered necessary to update the display at intervals greater than 100 milliseconds. Thus, the interrupt clocking signal CI to the central processing unit CPU interrupts the central processing unit, e.g. every 100 milliseconds, to initiate a mode of operation of the CPU which will result in the occurrence of high pulses along the control signals IOTI (if ST signal is high), IOTA and IOTD. Only one IOTI high pulse (enabling one occurrence of an input) will occur during the interval; however, a number of IOTA, then IOTD, high pulse sequences will occur during the interval, as the display includes a number of elements (e.g., alphanumeric digits and letters) for which the enabling of updating is required. Thus, the interrupt clocking unit essentially provides a slow clock to control the input of information by and the output of information to an individual. The control signals T1, T2, R and W will of course generally still be operative during the mode of operation triggered by the interrupt clocking signal, and the regulation of the flow rate of the fluid 14 will continue.
The control signals FS1 and FS2 are of great significance from a safety standpoint in that they are signals which check whether the central processing unit is acting in certain undesired ways or modes rather than in expected and desired modes. Thus, as the central processing unit CPU carries out its operations, receiving signal-represented information, transmitting address information and control signals R, W, T1 and T2, and IOT, the central processing unit will if it is not functioning in certain undesired ways, and assuming other "secondary" events related to the FS1 and FS2 signals occur, cause high pulses to occur along the control signals FS1 and FS2 at expected intervals to fail safe relay circuitry 40. This circuitry, implemented along conventional lines (e.g., charge on a capacitor dependent upon frequency of high pulses) will maintain a relay responsive to each of these control signals closed if it receives high pulses along the signal at frequent enough intervals. Each relay, in series with the other relay, will however open if the high pulses are not frequent enough. In this regard, it may be considered desirable to allow for the absence of a number of expected pulses before the relay opens, indicative, e.g., of a clear case of an undesired mode. This checking capability is particularly critical, for in its absence a patient could continue to receive a drug while the system may appear to act generally normally while operating abnormally. Since the control signals FS1 and FS2 relate in some respects to the operation of the memory-display and fail safe interface 62, they will be addressed in more detail after the operation of that interface has been described in connection with the updating of the display.
Somewhat similar concerns are present with regard to the frequency detector 28 and its detection of the frequency of the clocking signal C. As one illustrative example, the clocking unit 30 may fail in a fashion causing its frequency to double. In such a case the system, in the absence of a check stemming from the frequency detector 28, might continue to operate, but at twice the expected rate.
The operation of the digital to analog conversion system 56, analog to digital conversion system 60, analog device selector 31, memory-display and fail safe interface 62 and display panel DP is in large part readily evident by reference to FIG. 1 and the above table. Regarding the digital to analog conversion system 56, during a central processing unit cycle in which the implementation of a flow rate for a new infusion number is to be commenced, the control signal IOTLI will have a high interval which, along its falling edge, will cause a first input register in the system to store input information, including lower order bits of the digital representation to be converted to the analog signal for controlling the flow rate. During a subsequent cycle, which may conveniently be the next cycle, a second input register will store, along the falling edge of the control signal IOTHI, input information, including higher order bits of the just-mentioned digital representation. This two-step transfer is required in FIG. 1 due to the assumption of generally eight-bit parallel communication, and a similar assumption that more than 8 bits are used in the conversion process. Then, during another subsequent cycle, which again may conveniently be the next one, a high interval along the signal IOTC AND LCR from an AND gate 66, along its falling edge, will cause an internal conversion register in the digital to analog conversion system to store both the lower and higher order bits which it receives from the input registers. Bits in this register are the bits upon which the conversion is performed. The high LCR interval is from a high bit in a memory M storage location which is being addressed. The use of memory bits for essentially control purposes, as here, is of some interest; however, satisfactory alternatives, including the incorporation of an additional control signal from the IOT and testing controller 52 are readily apparent.
Now referring to the analog device selector 31, a high interval along the control signal IOTS permits the analog device selector 31 to receive addressing information from the memory representative of an upcoming selection of the power signal V1, of the output signal of the frequency detector 28 or of the output signal of the digital to analog conversion system 56. This addessing information will be stored in an address register in the selector along the falling edge of the control signal IOTS. These events result, along conventionally implemented lines, in the selection by the selector 31 of one of the three generally analog signals for transmittal to the analog to digital conversion system 60. By way of example, it will be assumed that the output of the digital to analog conversion system 56 has just been selected.
During a "read" cycle subsequent to the selection cycle, which could conveniently be the next cycle, a high interval along the control signal IOTC, interacting with a high LCR interval from a bit in an addressed storage location in memory and a second AND gate 68 will, along lines described above with regard to the digital to analog conversion system, commence the analog to digital conversion by the conversion system 60. This will occur along the falling edge of the high IOTC interval. Then, during subsequent "write" cycles, bits, first including lower order bits, and then higher order bits, of the digital representation resulting from the conversion, will be transmitted from an output register in the system for receipt by the RAM 23 and storage by the RAM in addressed storage locations. The first and second of these cycles will, respectively, be characterized by high intervals, enabling the transmittal by the conversion system, along the control signals IOTLO and IOTHO. Following the receipt of the digital representation, the central processing unit CPU and memory M will interact along conventional lines to compare the received information with information already stored in the RAM 23 which was the source of the signal converted to analog form by the digital to analog conversion system 56. In the event of a discrepancy, after the occurrence of the next interrupt of the central processing unit by the interrupt clocking signal, a warning signal, the word SERVICE, will be provided by the display panel, and, in addition, the output of flow rate information to the infusion pump may be ceased--i.e., a zero output level to the infusion pump IP may be established, or deactivation of the output may be implemented, all under the control of the ROM(B) program.
The testing of the output signal from the frequency detector and of the power signal V1 is along analogous lines. However, in these cases, since the standards for the frequency detector output signal and for the power supply signal V1 may be essentially permanently programmed into the system, the predetermined standards may be stored in digitally represented form on a permanent basis in the ROM(B) 44 rather than on a temporary basis in the RAM 23. Also, different warning signals and/or consequences may be provided as noted in connection with the description of the updating of the display, to follow.
Referring to the process of updating the display, as previously noted such updating may occur at intervals, e.g. 100 milliseconds, the onset of such an interval being controlled by the interrupt clocking signal CI. Thus, typically, during a cycle after the onset of an interrupt, the control signal IOTA will go high, causing an address register in the interface to receive signals from the RAM 23 for addressing an element of the display panel DP, and to store such signal along the falling edge of the high interval. Then, during a subsequent, conveniently the next, cycle, a data register in the memory-display interface 62 will similarly receive and store a data signal for that display element. In the case of a liquid crystal display element for a number, to e.g. display the digit 5, a single control bit will be received with the data, causing a high level along the signal CC which will trigger the receipt by the display panel circuitry of the data from the data register, and the subsequent storage (along the falling edge) of the data by a register for that element. The so stored digital signal, in the register for the element, will then determine which liquid crystal portions of the element are excited by the oscillation signals conventionally incorporated into display panel circuitry uitilizing liquid crystals, causing a 5 to appear in that display element. In this regard, it is again noted that successive occurrences of high intervals along the control signals IOTA and IOTD will typically occur after the onset of each interrupt so that many or all of the display elements may be updated essentially every 100 milliseconds.
Besides, e.g. the various alphanumeric information which may be provided by the display panel, the sound alarm 36, first warning light 32 and second warning light 34, previously noted, are also incorporated in the display panel DP of FIG. 1.
In the apparatus of FIG. 1, the first warning light 32 is employed to indicate that the central processing unit has, through the selective testing process described earlier, detected that the first battery pack in the power supply 26 was putting out insufficient power and that as a result, the power supply has received a high IC AND SBP interval during a "read" cycle causing it to switch in the second power supply. The first warning light will then be turned on through addressing and data information channeled through the memory-display and fail safe interface 62, along lines previously noted, with a high CWL interval provided in the same fashion as the aforementioned high CC. Similarly, the second warning light 34 will be similarly activated following the next interrupt after a detection of an input of a rate, through an ADJUST modification, exceeding the maximum of the infusion pump IP, e.g. 99.9 milliliters per hour.
Additionally, the alarm is addressed and activated as a result of an indication, through the selective testing, that the second battery pack is low, or that the frequency of the clocking unit has diverged from the predetermined standards for it. In this regard, the beeping rate of the alarm may be varied to indicate one or the other of these occurrences. Thus, the sound alarm 26 itself has several addresses, the receipt of activating data at one, activating one beeping rate, and the receipt of activating data at the other causing the onset of a second beeping rate. With the occurrence of both conditions, the sum beeping signal will then occur. Alternatively, for example, such rates might be controlled by the rate of channeling of activating data (an activating signal) to a single address for the alarm.
It is also noted that it is considered useful to activate the alarm upon the end of a sequence in which a continuation of the flow rate of the last infusion number has not been indicated. A different beeping frequency then might be employed for this condition. The employment of warning lights, warning sound alarms and alphanumeric warning information (e.g. SERVICE) may of course be varied. For example, the SERVICE alphanumeric information and sound alarm might together be employed to indicate a check sum on the flow rate information in the RAM has come up with a discrepancy with respect to an originally stored sum, or that the output signal of the digital to analog conversion system has become zero or been deactivated as a result of the determination that it did not correspond to the stored, digitally-represented output level in the RAM. Such variations may be readily implemented along the lines described above. Warnings such as the above in effect act as an interface between the selective testing capability and other safety aspects of the apparatus and an individual monitoring the operation of the apparatus, continually or at intervals, and possibly from a distance.
Returning to the control signals FS 1 and FS2, their generation may now readily be understood. Continuing with the assumption of generally 8-bit, parallel communication in the apparatus of FIG. 1, it is further assumed that the number of display elements to be addressed through the address register in the memory-display and fail safe interface 62 does not require more than 6 bits to accomplish the addressing. There will then be at least 2 bits remaining in, e.g., the address code for addressing the last digit in the elapsed time indicated by the display. For example, the address for this digit might be 111010, where the unused bits are of no concern with respect to such addressing.
Utilizing this situation, in FIG. 1, the two otherwise unused bits stored in the memory storage location from which the address for this digit is obtained are assumed to be set to 10, a code essentially arbitrarily chosen. For addressing the other display elements, the unused bits may, for example, be filled with zeros, or codes other than 10. Then, when the element for this digit is addressed, logic circuitry, including a first fail safe AND gate 70 and an inverter 72 will, through the occurrence of a high interval along the control signal FS 1, indicate that the central processing unit CPU has correctly functioned to the extent of reaching this point (as well as that other events required to achieve the high interval have occurred).
Similarly, with respect to the data used in updating, e.g. the last digit in the elapsed time, for which only 4 of 8 available bits will be required, after the storage location for the data to be used for a given update has been determined (by the central processing unit), the central processing unit, under the control of the PROM(B) program, will write an essentially arbitrarily chosen code, assumed to be 1010 in FIG. 1, in the otherwise unused 4 bits. Then a second fail safe AND gate 74 and two associated inverters 76 and 78 will, assuming the required events, including CPU operations, have occurred, cause a high interval along the control signal FS2 as the display data for the digit is provided by the interface to the display. The 4-bit code will be "erased" by the central processing unit from the storage location, under the control of the PROM(B) program, subsequent to its use. It may be appreciated that this check on the desired operation of the central processing unit (as well as other aspects of the apparatus) is perhaps more extensive than that through the control signal FS 1.
Given the foregoing, the control signals FS1 and FS2 may then interact with the fail safe relay circuitry 40 in the manner previously described.
It is noted that, if desired, the control signals FS1 and FS2 could additionally be used to deactivate the output upon the occurrence of other problems in the apparatus (e.g., related to the clocking signal frequency, power signal V1 or output of the analog to digital converter, discovered by selective testing) beyond certain undesired modes of operation of the central processing unit. However, the role of such control signals in checking for such undesired modes of operation which might otherwise go undetected is deemed to be of great importance. From a different perspective, each of the control signals FS1 and FS2 is of course used to indicate the absence of certain undesired modes of operation of the central processing unit CPU.
In view of the above description, it may be seen that the apparatus herein may be variously implemented and variously used depending upon specific applications. For example, the fluid flow rate could alternatively relate to a liquid which is being vaporized for inhalation by a patient; the output to a regulator could indicate a flow rate through its frequency or more directly, through a binary word, which output forms might be accepted by various regulators; control over relatively low rates of flow and small variations might be accomplished by regulation incorporating a piezoelectric material excited in varying degrees; and the regulation could incorporate the use of a bottle for a liquid equipped, for example, with a drip device, a piston-driven cassette drive or a peristaltic pump device. Accordingly, the scope hereof shall not be referenced to the disclosed embodiments, but on the contrary, shall be determined in accordance with the claims as set forth below.
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US3809871 *||1 Dic 1972||7 May 1974||Nasa||Programmable physiological infusion|
|US3946731 *||31 Jul 1974||30 Mar 1976||Lichtenstein Eric Stefan||Apparatus for extracorporeal treatment of blood|
|US4080966 *||12 Ago 1976||28 Mar 1978||Trustees Of The University Of Pennsylvania||Automated infusion apparatus for blood pressure control and method|
|US4094318 *||9 Jul 1976||13 Jun 1978||Burron Medical Products, Inc.||Electronic control means for a plurality of intravenous infusion sets|
|US4114188 *||5 Ene 1977||12 Sep 1978||National Research Development Corporation||Apparatus for indicating uterine activity in labor|
|US4151845 *||25 Nov 1977||1 May 1979||Miles Laboratories, Inc.||Blood glucose control apparatus|
|US4165532 *||30 Dic 1977||21 Ago 1979||The Toro Company||Automatic irrigation sprinkler system controller|
|US4184815 *||14 Mar 1977||22 Ene 1980||Extracorporeal Medical Specialties, Inc.||Roller pump rotor with integral spring arms|
|1||*||"A Computer Program for Xylocaine Infusion Regimens", Federation Proceedings, vol. 32, No. 3, p. 812, Aab, 1973, Jelliffe.|
|2||*||"A Device for the Precise Reg. of Blood Press. in Patients During Surg. and Hypertensive Crises", R. T. McNally et al., San Diego Biomed. Symposium, Feb. 2-4, 77, vol. XVI (1977), pp. 419-424.|
|3||*||"A Package of Time Shared Computer Programs for Patient Care", Jelliffe et al., pp. 154-162, Published in or after 1976.|
|4||*||"An Improved Computer Program for Lidocaine Infusion Regimens", Clinical Research, vol. 23, p. 125A, Feb. 1975, Jelliffe et al.|
|5||*||"An Optimal Expotential Intravenous Infusor", Collins et al., 30th ACEMB, Nov. 5-9, 1977, section 13.2.|
|6||*||"Clinical Studies with Computer-Assisted Lidocaine (L) Infusion Regimens", Circulation, vol. 54, No. 4, Sup. II, p. 211, 1976, Jelliffe et al.|
|7||*||"Dose-Regulated Penthane (Methoxyflurane) Anesthesia", Harry Lowe, 1977, pp. 99-109, Chapt. 7, Auto. Programmed Anesthesia.|
|8||*||"Regulation of Mean Arterial Pressure by Comp. Control of Vasoactive Agents in Post-Op. Patients", _Computers in Cardiology, 1975, pp. 91-94.|
|9||*||"Therap. Uses of Na Nitroprusside and an Automated Method of Administration", A. D. Ivankovich, Ed. International Anesthesiology Clinics, Little Brown, vol. 16, #2, 1978, pp. 51-88.|
|10||*||Auto-Syringe Inc., General Informational Brochure for Models AS*2B, AS*2C, AS*2F, AS*3B, AS*5B, Hooksoft.|
|11||*||Calfee, R. V. et al., "Closed Loop Control of Blood Pressure in Hypertensive Crisis", 30th ACEMB Los Angeles, Cal., Nov. 5-9, 1977, p. 388.|
|12||*||Fukui, Y. et al., "Digital and Sampled-Data Control of Arterial BP During Halothane Anesthesia", Proc. San Diego Biomed. Symp. 1974, pp. 273-278.|
|13||*||Operating Instructions and Specs. for IMED, Mod. 929, Computer Controlled Infusion Pump, 6/1979.|
|14||*||Products for Science--Cole-Parmer Inst. Co., Masterflex.RTM. pumps, p. 11.|
|15||Products for Science--Cole-Parmer Inst. Co., Masterflex® pumps, p. 11.|
|16||*||Research Inc. Catalog-Data-Trak.RTM. Model 5500.|
|17||Research Inc. Catalog-Data-Trak® Model 5500.|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US4395259 *||14 Sep 1981||26 Jul 1983||Siemens Aktiengesellschaft||Device for the infusion of fluids into the human or animal body|
|US4529401 *||11 Ene 1982||16 Jul 1985||Cardiac Pacemakers, Inc.||Ambulatory infusion pump having programmable parameters|
|US4560979 *||20 Mar 1984||24 Dic 1985||Intermedicat Gmbh||Method for triggering an alarm in an infusion syringe|
|US4573994 *||7 Dic 1981||4 Mar 1986||The Johns Hopkins University||Refillable medication infusion apparatus|
|US4589372 *||4 Mar 1985||20 May 1986||The University Of Toledo||Dispensing system having weight dependent control means|
|US4613327 *||10 Sep 1985||23 Sep 1986||Tegrarian Haig V||Apparatus for infusing blood and other related fluids into a patient's body|
|US4619653 *||4 Nov 1982||28 Oct 1986||The Johns Hopkins University||Apparatus for detecting at least one predetermined condition and providing an informational signal in response thereto in a medication infusion system|
|US4624661 *||6 May 1985||25 Nov 1986||Surgidev Corp.||Drug dispensing system|
|US4629686 *||14 Jun 1982||16 Dic 1986||Endotronics, Inc.||Apparatus for delivering a controlled dosage of a chemical substance|
|US4676776 *||18 Ene 1985||30 Jun 1987||Intelligent Medicine, Inc.||Device and method for effecting application of a therapeutic agent|
|US4709331 *||1 May 1984||24 Nov 1987||Barkett Patricia A||Calculator-computer for calculating infusion rates over varying time intervals|
|US4718576 *||23 Dic 1985||12 Ene 1988||Oximetrix, Inc.||Fluid infusion pumping apparatus|
|US4722734 *||18 Jul 1986||2 Feb 1988||Ferring Biotechnik, Gmbh||Device for the intermittent pulsatory application of liquid pharmaceuticals|
|US4725964 *||30 Ene 1985||16 Feb 1988||Glaxo Group Limited||Computer controlled adapter unit for fluid system control|
|US4731051 *||15 Feb 1983||15 Mar 1988||The Johns Hopkins University||Programmable control means for providing safe and controlled medication infusion|
|US4731726 *||19 May 1986||15 Mar 1988||Healthware Corporation||Patient-operated glucose monitor and diabetes management system|
|US4756706 *||21 Ene 1986||12 Jul 1988||American Hospital Supply Corporation||Centrally managed modular infusion pump system|
|US4784645 *||12 Sep 1986||15 Nov 1988||The Johns Hopkins University||Apparatus for detecting a condition of a medication infusion system and providing an informational signal in response thereto|
|US4785799 *||18 Feb 1988||22 Nov 1988||American Hospital Supply Corporation||Method and apparatus for automatic profiled infusion in cyclic TPN|
|US4807170 *||25 Mar 1986||21 Feb 1989||John Kulli||Drug dose rate calculator|
|US4810243 *||29 Jun 1987||7 Mar 1989||Intelligent Medicine, Inc.||Device and method for effecting application of a therapeutic agent|
|US4828545 *||16 Abr 1987||9 May 1989||Omni-Flow, Inc.||Pressure responsive multiple input infusion system|
|US4838856 *||2 Jul 1987||13 Jun 1989||Truckee Meadows Research & Development||Fluid infusion flow control system|
|US4839790 *||5 Oct 1987||13 Jun 1989||Tokyo Gas Co., Ltd.||Gas accident preventive unit|
|US4850972 *||16 Ene 1987||25 Jul 1989||Pacesetter Infusion, Ltd.||Progammable multiple pump medication infusion system with printer|
|US4854324 *||24 Feb 1988||8 Ago 1989||Medrad, Inc.||Processor-controlled angiographic injector device|
|US4898578 *||26 Ene 1988||6 Feb 1990||Baxter International Inc.||Drug infusion system with calculator|
|US5088981 *||31 Jul 1987||18 Feb 1992||Howson David C||Safety enhanced device and method for effecting application of a therapeutic agent|
|US5100380 *||16 May 1989||31 Mar 1992||Abbott Laboratories||Remotely programmable infusion system|
|US5171301 *||15 Oct 1991||15 Dic 1992||Imed Corporation||Multiple mini-pump infusion system|
|US5256156 *||13 Ene 1992||26 Oct 1993||Baxter International Inc.||Physician closed-loop neuromuscular blocking agent system|
|US5304126 *||31 Dic 1990||19 Abr 1994||Abbott Laboratories||Infusion system having plural fluid flow lines|
|US5304127 *||2 Abr 1993||19 Abr 1994||Sharp Kabushiki Kaisha||Infusion apparatus able to recognize an appropriate time for servicing|
|US5368562 *||30 Jul 1993||29 Nov 1994||Pharmacia Deltec, Inc.||Systems and methods for operating ambulatory medical devices such as drug delivery devices|
|US5464392 *||7 Mar 1994||7 Nov 1995||Abbott Laboratories||Infusion system having plural fluid input ports and at least one patient output port|
|US5608650 *||19 Ago 1994||4 Mar 1997||Spectrel Partners, L.L.C.||Systems and methods for testing pump flow rates|
|US5658250 *||8 Nov 1995||19 Ago 1997||Sims Deltec, Inc.||Systems and methods for operating ambulatory medical devices such as drug delivery devices|
|US5717603 *||27 Jun 1996||10 Feb 1998||Spectrel Partners, L.L.C.||Integrated test station for testing liquid flow and electrical safety characteristics of IV pumps|
|US5742519 *||28 Sep 1995||21 Abr 1998||Spectrel Partners, L.L.C.||Integrated systems for testing and certifying the physical, functional, and electrical performance of IV pumps|
|US5772635 *||15 May 1995||30 Jun 1998||Alaris Medical Systems, Inc.||Automated infusion system with dose rate calculator|
|US5856929 *||19 Ago 1994||5 Ene 1999||Spectrel Partners, L.L.C.||Integrated systems for testing and certifying the physical, functional, and electrical performance of IV pumps|
|US5935099 *||10 Ene 1997||10 Ago 1999||Sims Deltec, Inc.||Drug pump systems and methods|
|US6070761 *||22 Ago 1997||6 Jun 2000||Deka Products Limited Partnership||Vial loading method and apparatus for intelligent admixture and delivery of intravenous drugs|
|US6186977||24 Abr 1997||13 Feb 2001||Joseph L. Riley Anesthesia Associates||Apparatus and method for total intravenous anesthesia delivery and associated patient monitoring|
|US6259587||17 Jun 1999||10 Jul 2001||Minimed Inc.||Direct current motor safety circuits for fluid delivery systems|
|US6641556 *||6 Jul 1999||4 Nov 2003||Respiratory Support Products, Inc.||Intravenous fluid heating system|
|US6650951||19 Jun 2000||18 Nov 2003||International Business Machines Corporation||Method and insulin pump for providing a forgotten bolus warning|
|US6757630||17 Jun 2002||29 Jun 2004||Mediq/Prn Life Support Services, Inc.||Integrated systems for testing and certifying the physical, functional, and electrical performance of IV pumps|
|US6790198||31 Oct 2000||14 Sep 2004||B-Braun Medical, Inc.||Patient medication IV delivery pump with wireless communication to a hospital information management system|
|US6807965||3 Jun 1999||26 Oct 2004||Scott Laboratories, Inc.||Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures|
|US6985870||11 Ene 2002||10 Ene 2006||Baxter International Inc.||Medication delivery system|
|US6986347||23 Jul 2001||17 Ene 2006||Scott Laboratories, Inc.||Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures|
|US6997905||14 Jun 2002||14 Feb 2006||Baxter International Inc.||Dual orientation display for a medical device|
|US7018361||14 Jun 2002||28 Mar 2006||Baxter International Inc.||Infusion pump|
|US7056307||2 Jun 2003||6 Jun 2006||Smith James E||Weight dependent, automatic filling dosage system and method of using same|
|US7155284||16 Ene 2003||26 Dic 2006||Advanced Bionics Corporation||Treatment of hypertension|
|US7201734||3 Ago 2004||10 Abr 2007||Scott Laboratories, Inc.||Apparatus for drug delivery in association with medical or surgical procedures|
|US7236936||30 Dic 2002||26 Jun 2007||B. Braun Medical, Inc.||Security infusion pump with bar code reader|
|US7247154||3 Ago 2004||24 Jul 2007||Scott Laboratories, Inc||Method for drug delivery in association with medical or surgical procedures|
|US7347836||5 Feb 2002||25 Mar 2008||Smiths Medical, Inc.||Drug pump systems and methods|
|US7520871||21 Sep 2004||21 Abr 2009||Lma North America, Inc||System and method for tension-activated fluid control|
|US7527052||25 Feb 2003||5 May 2009||Scott Laboratories, Inc.||Fail-safe module integral with a sedation and analgesia system and method|
|US7527608||30 Jul 2004||5 May 2009||Lma North America, Inc.||Medication infusion and aspiration system and method|
|US7539537||3 Oct 2003||26 May 2009||Scott Laboratories, Inc.||Systems and methods for providing sensor fusion|
|US7608060||28 Dic 2005||27 Oct 2009||Baxter International Inc.||Infusion pump|
|US7645258||13 Mar 2004||12 Ene 2010||B. Braun Medical, Inc.||Patient medication IV delivery pump with wireless communication to a hospital information management system|
|US7654976||31 Oct 2007||2 Feb 2010||Smiths Medical Asd, Inc.||Drug pump systems and methods|
|US7668731||24 Nov 2003||23 Feb 2010||Baxter International Inc.||Medication delivery system|
|US7905710||25 Ago 2006||15 Mar 2011||Hospira, Inc.||System and method for improved low flow medical pump delivery|
|US7967806||25 Mar 2004||28 Jun 2011||Medtronic, Inc.||Method of delivering a fluid medication to a patient in flex mode|
|US7967812||22 Oct 2002||28 Jun 2011||Medtronic, Inc.||Drug infusion system programmable in flex mode|
|US7970631||21 Jun 2005||28 Jun 2011||Ethicon Endo-Surgery, Inc.||Medical effector system|
|US8028694||3 Oct 2003||4 Oct 2011||Scott Laboratories, Inc.||Systems and methods for providing trend analysis in a sedation and analgesia system|
|US8105269||24 Oct 2008||31 Ene 2012||Baxter International Inc.||In situ tubing measurements for infusion pumps|
|US8133197||2 May 2008||13 Mar 2012||Smiths Medical Asd, Inc.||Display for pump|
|US8137083||11 Mar 2009||20 Mar 2012||Baxter International Inc.||Infusion pump actuators, system and method for controlling medical fluid flowrate|
|US8149131||3 Ago 2006||3 Abr 2012||Smiths Medical Asd, Inc.||Interface for medical infusion pump|
|US8234128||30 Dic 2003||31 Jul 2012||Baxter International, Inc.||System and method for verifying medical device operational parameters|
|US8250483||28 Feb 2002||21 Ago 2012||Smiths Medical Asd, Inc.||Programmable medical infusion pump displaying a banner|
|US8313308||26 Mar 2004||20 Nov 2012||Hospira, Inc.||Medical infusion pump with closed loop stroke feedback system and method|
|US8382447||31 Dic 2009||26 Feb 2013||Baxter International, Inc.||Shuttle pump with controlled geometry|
|US8435206||5 Feb 2007||7 May 2013||Smiths Medical Asd, Inc.||Interface for medical infusion pump|
|US8480655||21 Jun 2011||9 Jul 2013||Medtronic, Inc.||Drug infusion system programmable in flex mode|
|US8486019||22 Abr 2009||16 Jul 2013||B. Braun Medical, Inc.||Patient medication IV delivery pump with wireless communication to a hospital information management system|
|US8496613||30 Ene 2012||30 Jul 2013||Baxter International Inc.||In situ tubing measurements for infusion pumps|
|US8504179||28 Feb 2002||6 Ago 2013||Smiths Medical Asd, Inc.||Programmable medical infusion pump|
|US8555876||17 Abr 2009||15 Oct 2013||Scott Laboratories, Inc.||Fail-safe module integral with a sedation and analgesia system and method|
|US8567235||29 Jun 2010||29 Oct 2013||Baxter International Inc.||Tube measurement technique using linear actuator and pressure sensor|
|US8567393||1 Nov 2002||29 Oct 2013||Scott Laboratories, Inc||User interface for sedation and analgesia delivery systems and methods|
|US8612055 *||16 Abr 2010||17 Dic 2013||Medtronic, Inc.||System and method for delivering a therapeutic agent according to default infusion schedule|
|US8690856||25 May 2012||8 Abr 2014||Smiths Medical Asd, Inc.||Insulin pump having missed meal bolus alarm|
|US8696632||5 Oct 2009||15 Abr 2014||Baxter International Inc.||Infusion pump with battery operation capability|
|US8771251||16 Dic 2010||8 Jul 2014||Hospira, Inc.||Systems and methods for managing and delivering patient therapy through electronic drug delivery systems|
|US8775196||30 Dic 2003||8 Jul 2014||Baxter International Inc.||System and method for notification and escalation of medical data|
|US8777923||26 Oct 2010||15 Jul 2014||Ethicon Endo-Surgery, Inc.||Patient monitoring and drug delivery system and method of use|
|US8823528||25 May 2012||2 Sep 2014||Smiths Medical Asd, Inc.||Infusion pump having an alarm signal|
|US8858526||3 Ago 2006||14 Oct 2014||Smiths Medical Asd, Inc.||Interface for medical infusion pump|
|US8888738||10 Ago 2011||18 Nov 2014||Baxter International Inc.||Infusion pump with multiple orientation display|
|US8936573||12 Dic 2013||20 Ene 2015||Smiths Medical Asd, Inc.||Infusion pump having missed bolus alarm|
|US8952794||13 Mar 2012||10 Feb 2015||Smiths Medical Asd, Inc.||Interface for medical infusion pump|
|US8954336||22 Feb 2005||10 Feb 2015||Smiths Medical Asd, Inc.||Server for medical device|
|US8965707||3 Ago 2006||24 Feb 2015||Smiths Medical Asd, Inc.||Interface for medical infusion pump|
|US9022974||12 Ene 2012||5 May 2015||The Regents Of The University Of California||System and method for closed-loop patient-adaptive hemodynamic management|
|US20020183693 *||5 Feb 2002||5 Dic 2002||Sims Deltec, Inc.||Drug pump systems and methods|
|US20020184369 *||31 May 2001||5 Dic 2002||Parkinson Steven William||Appointment scheme for redistributing service access|
|US20030135087 *||1 Nov 2002||17 Jul 2003||Scott Laboratories, Inc.||User interface for sedation and analgesia delivery systems and methods|
|US20030139701 *||30 Dic 2002||24 Jul 2003||B. Braun Medical, Inc.||Security infusion pump with bar code reader|
|US20030140928 *||30 Abr 2002||31 Jul 2003||Tuan Bui||Medical treatment verification system and method|
|US20030163088 *||28 Feb 2002||28 Ago 2003||Blomquist Michael L.||Programmable medical infusion pump|
|US20030163789 *||28 Feb 2002||28 Ago 2003||Blomquist Michael L.||Programmable medical infusion pump displaying a banner|
|US20030201697 *||7 Feb 2003||30 Oct 2003||Richardson William R.||Storage device for health care facility|
|US20030204419 *||31 May 2002||30 Oct 2003||Wilkes Gordon J.||Automated messaging center system and method for use with a healthcare system|
|US20030217747 *||25 Feb 2003||27 Nov 2003||Scott Laboratories, Inc.||Fail-safe module integral with a sedation and analgesia system and method|
|US20030222548 *||31 May 2002||4 Dic 2003||Richardson William R.||Storage device for health care facility|
|US20030225596 *||31 May 2002||4 Dic 2003||Richardson Bill R.||Biometric security for access to a storage device for a healthcare facility|
|US20030233069 *||14 Jun 2002||18 Dic 2003||John Gillespie||Infusion pump|
|US20040015123 *||2 Jun 2003||22 Ene 2004||Animal Innovations, Inc.||Weight dependent, automatic filling dosage system and method of using same|
|US20040015137 *||14 Jul 2003||22 Ene 2004||Dentsply Research & Development Corp.||Fluid material dispensing syringe|
|US20040077997 *||22 Oct 2002||22 Abr 2004||Jasperson Keith E.||Drug infusion system programmable in flex mode|
|US20040104271 *||24 Nov 2003||3 Jun 2004||James Martucci||Medication delivery system|
|US20040167804 *||30 Dic 2003||26 Ago 2004||Simpson Thomas L.C.||Medical data communication notification and messaging system and method|
|US20040172222 *||30 Dic 2003||2 Sep 2004||Simpson Thomas L. C.||System and method for notification and escalation of medical data|
|US20040172300 *||30 Dic 2003||2 Sep 2004||Mihai Dan M.||Method and system for integrating data flows|
|US20040172301 *||30 Dic 2003||2 Sep 2004||Mihai Dan M.||Remote multi-purpose user interface for a healthcare system|
|US20040176667 *||30 Dic 2003||9 Sep 2004||Mihai Dan M.||Method and system for medical device connectivity|
|US20040176984 *||13 Mar 2004||9 Sep 2004||B-Braun Medical, Inc.|
|US20040181204 *||25 Mar 2004||16 Sep 2004||Jasperson Keith E.||Method of delivering a fluid medication to a patient in flex mode|
|US20040193325 *||25 Mar 2003||30 Sep 2004||David Bonderud||Method and apparatus to prevent medication error in a networked infusion system|
|US20050010165 *||3 Ago 2004||13 Ene 2005||Scott Laboratories||Method for drug delivery in association with medical or surgical procedures|
|US20050010166 *||3 Ago 2004||13 Ene 2005||Scott Laboratories||Apparatus for drug delivery in association with medical or surgical procedures|
|US20050039742 *||3 Oct 2003||24 Feb 2005||Scott Laboratories, Inc.||Systems and methods for providing trend analysis in a sedation and analgesia system|
|US20050065817 *||30 Dic 2003||24 Mar 2005||Mihai Dan M.||Separation of validated information and functions in a healthcare system|
|US20050214129 *||26 Mar 2004||29 Sep 2005||Greene Howard L||Medical infusion pump with closed loop stroke feedback system and method|
|US20050246416 *||22 Feb 2005||3 Nov 2005||Blomquist Michael L||Server for medical device|
|US20050273079 *||10 Oct 2001||8 Dic 2005||Hohlfelder Ingrid E||Fluid material dispensing syringe|
|US20060081259 *||21 Jun 2005||20 Abr 2006||Bruggeman Paul J||Medical effector system|
|US20060184123 *||28 Dic 2005||17 Ago 2006||Gillespie John Jr||Infusion pump|
|US20070058412 *||25 Ago 2006||15 Mar 2007||Wang David T||System and method for improved low flow medical pump delivery|
|US20070078380 *||21 Sep 2004||5 Abr 2007||Marc Yap||System and method for tension-activated fluid control|
|US20070250010 *||12 Jun 2007||25 Oct 2007||Hohlfelder Ingrid E||Fluid material dispensing syringe|
|US20080033361 *||5 Feb 2007||7 Feb 2008||Smiths Medical Md, Inc.||Interface for medical infusion pump|
|US20080033749 *||3 Ago 2006||7 Feb 2008||Blomquist Michael L||Interface for medical infusion pump|
|US20080034323 *||3 Ago 2006||7 Feb 2008||Blomquist Michael L||Interface for medical infusion pump|
|US20080126969 *||3 Ago 2006||29 May 2008||Blomquist Michael L||Interface for medical infusion pump|
|US20080188795 *||2 Feb 2007||7 Ago 2008||Katz Hal H||Patient monitoring and drug delivery system and method of use|
|US20090012812 *||6 Mar 2008||8 Ene 2009||Tracy Rausch||System and method for patient care|
|US20090157219 *||2 May 2008||18 Jun 2009||Parker Jr Lance T||Intelligent Sleeve Container for Use in a Controlled Syringe System|
|US20090182265 *||25 Mar 2009||16 Jul 2009||Lma North America, Inc||Medication infusion system and method|
|US20090182307 *||24 Mar 2009||16 Jul 2009||Lma North America, Inc.||System and Method for Tension-Activated Fluid Control|
|US20090199851 *||17 Abr 2009||13 Ago 2009||Scott Laboratories, Inc||Fail-safe module integral with a sedation and analgesia system and method|
|US20090203329 *||22 Abr 2009||13 Ago 2009||B. Braun Medical, Inc.||Patient Medication IV Delivery Pump with Wireless Communication to a Hospital Information Management System|
|US20100016796 *||15 Sep 2009||21 Ene 2010||Animal Innovations, Inc.||Syringe Mechanism for Detecting Syringe Status|
|US20100106082 *||24 Oct 2008||29 Abr 2010||Baxter International Inc.||In situ tubing measurements for infusion pumps|
|US20100256561 *||5 Oct 2009||7 Oct 2010||Baxter International Inc.||Infusion pump with battery operation capability|
|US20110040158 *||26 Oct 2010||17 Feb 2011||Katz Hal H||Patient monitoring and drug delivery system and method of use|
|US20110152830 *||16 Dic 2010||23 Jun 2011||Hospira, Inc.||Systems and methods for managing and delivering patient therapy through electronic drug delivery systems|
|US20110158823 *||31 Dic 2009||30 Jun 2011||Baxter International Inc.||Shuttle pump with controlled geometry|
|US20110257798 *||16 Abr 2010||20 Oct 2011||Medtronic, Inc.||System and method for delivering a therapeutic agent according to default infusion schedule|
|USRE36871 *||9 Mar 1995||12 Sep 2000||Abbott Laboratories||Remotely programmable infusion system|
|CN100563745C||25 Feb 2003||2 Dic 2009||斯科特实验室公司||Sedation and analgesia system|
|EP0154191A1 *||8 Feb 1985||11 Sep 1985||Abbott Laboratories||Infusion system having plural fluid input ports and at least one patient output port|
|WO1984000028A1 *||31 May 1983||5 Ene 1984||Endotronics Inc||Apparatus for delivering a controlled dosage of a chemical substance|
|WO1984001719A1 *||5 Oct 1983||10 May 1984||Univ Johns Hopkins||Apparatus for detecting at least one predetermined condition and providing an informational signal in response thereto in a medication infusion system|
|WO1984003218A1 *||17 Oct 1983||30 Ago 1984||Univ Johns Hopkins||Programmable control means for providing safe and controlled medication infusion|
|WO1994007186A1 *||17 Sep 1993||31 Mar 1994||Graseby Medical Limited||Program card|
|WO2000079676A1 *||16 Jun 2000||28 Dic 2000||Minimed Inc.||Direct current motor safety circuits for fluid delivery systems|
|WO2003072184A2 *||25 Feb 2003||4 Sep 2003||Scott Laboratories, Inc.||Fail-safe module integral with a sedation and analgesia system and method|
|WO2003072184A3 *||25 Feb 2003||20 Nov 2003||Scott Lab Inc||Fail-safe module integral with a sedation and analgesia system and method|
|WO2012097129A2 *||12 Ene 2012||19 Jul 2012||The Regents Of The University Of California||System and method for closed-loop patient-adaptive hemodynamic management|
|WO2012097129A3 *||12 Ene 2012||1 Nov 2012||The Regents Of The University Of California||System and method for closed-loop patient-adaptive hemodynamic management|
|Clasificación de EE.UU.||604/31, 604/67|
|Clasificación internacional||A61M5/172, G05D7/06, A61M5/00, A61M5/168|
|Clasificación cooperativa||A61M2005/14208, A61M5/172, A61M5/16831, G05D7/0676|
|Clasificación europea||A61M5/168D, G05D7/06F4D, A61M5/172|